vimarsana.com

Page 19 - பல்கலைக்கழகம் ஆஃப் பிராங்க்ஃபர்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Identity Politics Is a Tool to Break Down America: Expert

Identity Politics Is a Tool to Break Down America: Expert Identity politics is the reimagining of America as not a united country or a united nation but as a confederation of identity groups, according to Mike Gonzalez, a senior fellow on E Pluribus Unum at Heritage Foundation. “Some of these groups are considered to be oppressed and then one of these groups is the oppressor,” Gonzalez said on The Epoch Times’ “Crossroads” program. These groups have been created synthetically by activists on the left for the purpose of instilling the members of the oppressed groups with a sense of victimhood and grievances so they would act as a catalyst to change the society and to change America, Gonzalez said.

Mit Robinhood und Co an die Börse

Mit Robinhood und Co an die Börse
thueringer-allgemeine.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thueringer-allgemeine.de Daily Mail and Mail on Sunday newspapers.

Palleon Pharmaceuticals Appoints Nikola Trbovic to Its Board of Directors

Posted on 394 Palleon Pharmaceuticals, a company pioneering the field of glycan-mediated immune regulation to treat cancer and inflammatory diseases, today announced the appointment of Nikola Trbovic, Ph.D., Executive Director and Partner at Pfizer Ventures, as a member of its Board of Directors. “Nikola’s expertise in R&D and corporate finance will be an asset to Palleon, and we are very pleased to welcome him to the Board. Nikola will replace Bill Burkoth, who we would like to thank for the valuable support and guidance that he has given to Palleon over the years,” said Jim Broderick, M.D., Chief Executive Officer and Founder of Palleon. “This is an exciting time of growth for the company as our lead program, an enzymatic sialoglycan degrader for T cell exhaustion in cancer, is expected to enter clinical testing later this year. We look forward to working closely with Nikola as we advance our programs to first

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.